MARVELD3 siRNA (Human)
SiRNA to inhibit MARVELD3 expression using RNA interference
Product Specifications
Product Name Alternative
MRVLDC3; MARVEL domain-containing protein 3
Reactivity
H
Source
Synthetic
Applications
RNAi
Purity
> 97%
Form
Lyophilized powder
Components
We offers pre-designed sets of 3 different target-specific siRNA oligo duplexes of human MARVELD3 gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot.
Storage Conditions
Shipped at 4 °C. Store at -20 °C for one year.
Specificity
MARVELD3 siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression.
NCBI Gene Symbol
MARVELD3
Quality Control
Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
SwissProt (Human)
Q96A59
Entrez GeneHuman
91862
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
031521-FITC 200 µL
ACAP3, NT (ACAP3, CENTB5, KIAA1716, Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3, Centaurin-beta-5) (FITC) discontinued
Sign In for Pricing
View Details 
MBS6465097-01 0.2 mL
BCL2L13, CT (Bcl-2-like Protein 13, Bcl2-L-13, Protein Mil1, Bcl-rambo, MIL1, CD003) (AP)
Sign In for Pricing
View Details MBS6465097-02 5x 0.2 mL
BCL2L13, CT (Bcl-2-like Protein 13, Bcl2-L-13, Protein Mil1, Bcl-rambo, MIL1, CD003) (AP)
Sign In for Pricing
View Details